There is solid evidence that the anti-inflammatory activity of IVIg in CIDP crucially depends on the presence and up-regulation of FcγRIIB, which is the main driver of complement activation of the IgG fragment [27, 42, 45]. Here, FCGR2B is linked to chronic inflammatory demyelinating polyradiculoneuropathy.